FOXK2
Basic information
Region (hg38): 17:82519713-82644662
Previous symbols: [ "ILF", "ILF1" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the FOXK2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 15 | |||||
missense | 51 | 58 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 1 | |||||
splice donor/acceptor (+/-2bp) | 2 | |||||
splice region | 1 | 1 | 2 | |||
non coding | 5 | |||||
Total | 0 | 0 | 51 | 16 | 14 |
Variants in FOXK2
This is a list of pathogenic ClinVar variants found in the FOXK2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
17-82519895-G-T | not specified | Uncertain significance (Apr 13, 2022) | ||
17-82519901-G-C | not specified | Uncertain significance (Aug 16, 2022) | ||
17-82519901-G-T | not specified | Uncertain significance (May 02, 2024) | ||
17-82519932-C-T | not specified | Uncertain significance (Sep 06, 2022) | ||
17-82519935-CGGGCGGCGGGGCCGG-C | Likely benign (Dec 31, 2019) | |||
17-82519941-G-T | not specified | Uncertain significance (Sep 14, 2022) | ||
17-82519947-C-T | not specified | Uncertain significance (Sep 06, 2022) | ||
17-82519953-G-A | not specified | Uncertain significance (Aug 28, 2023) | ||
17-82519963-C-A | Likely benign (Jan 08, 2019) | |||
17-82520042-C-T | Premature ovarian insufficiency | Likely benign (Jul 21, 2018) | ||
17-82520116-C-T | Benign (Jun 18, 2018) | |||
17-82520186-C-T | not specified | Uncertain significance (May 17, 2023) | ||
17-82520211-G-A | not specified | Uncertain significance (Feb 22, 2023) | ||
17-82520283-C-T | not specified | Uncertain significance (May 16, 2023) | ||
17-82520306-G-A | not specified | Uncertain significance (Jan 31, 2024) | ||
17-82520314-G-T | Likely benign (Jul 25, 2017) | |||
17-82563382-A-G | not specified | Uncertain significance (Sep 27, 2021) | ||
17-82563392-C-T | not specified | Uncertain significance (Jul 11, 2022) | ||
17-82563427-C-G | not specified | Uncertain significance (Jan 04, 2022) | ||
17-82563473-C-T | not specified | Uncertain significance (Sep 22, 2023) | ||
17-82568137-A-G | not specified | Likely benign (Jan 03, 2024) | ||
17-82571738-G-T | Benign (Dec 31, 2019) | |||
17-82571776-C-T | not specified | Uncertain significance (Jan 17, 2023) | ||
17-82571784-C-T | not specified | Uncertain significance (Mar 29, 2024) | ||
17-82571807-C-T | Benign (Aug 15, 2018) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
FOXK2 | protein_coding | protein_coding | ENST00000335255 | 9 | 124950 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0255 | 0.974 | 125515 | 9 | 215 | 125739 | 0.000891 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.396 | 364 | 386 | 0.943 | 0.0000240 | 4173 |
Missense in Polyphen | 67 | 118.82 | 0.56387 | 1378 | ||
Synonymous | -2.65 | 227 | 182 | 1.25 | 0.0000132 | 1464 |
Loss of Function | 3.05 | 7 | 22.7 | 0.309 | 0.00000115 | 261 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00216 | 0.00184 |
Ashkenazi Jewish | 0.000203 | 0.000198 |
East Asian | 0.00452 | 0.00414 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.000267 | 0.000255 |
Middle Eastern | 0.00452 | 0.00414 |
South Asian | 0.00269 | 0.00255 |
Other | 0.000663 | 0.000652 |
dbNSFP
Source:
- Function
- FUNCTION: Transcriptional regulator that recognizes the core sequence 5'-TAAACA-3'. Binds to NFAT-like motifs (purine-rich) in the IL2 promoter (PubMed:1339390). Positively regulates WNT/beta- catenin signaling by translocating DVL proteins into the nucleus (PubMed:25805136). Also binds to HIV-1 long terminal repeat. May be involved in both positive and negative regulation of important viral and cellular promoter elements (PubMed:1909027). {ECO:0000269|PubMed:1339390, ECO:0000269|PubMed:1909027, ECO:0000269|PubMed:25805136}.;
- Pathway
- Post-translational protein modification;Metabolism of proteins;UCH proteinases;Deubiquitination
(Consensus)
Recessive Scores
- pRec
- 0.204
Intolerance Scores
- loftool
- 0.0444
- rvis_EVS
- -0.42
- rvis_percentile_EVS
- 25.84
Haploinsufficiency Scores
- pHI
- 0.522
- hipred
- Y
- hipred_score
- 0.685
- ghis
- 0.528
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.938
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Foxk2
- Phenotype
Gene ontology
- Biological process
- negative regulation of transcription by RNA polymerase II;regulation of transcription, DNA-templated;regulation of transcription by RNA polymerase II;protein deubiquitination;positive regulation of transcription by RNA polymerase II
- Cellular component
- nucleus;nucleoplasm
- Molecular function
- magnesium ion binding;transcription regulatory region sequence-specific DNA binding;RNA polymerase II proximal promoter sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;DNA-binding transcription activator activity, RNA polymerase II-specific;DNA-binding transcription factor activity;protein binding;sequence-specific DNA binding